Target intelligence / Profile preview

Alkaline phosphatase 1 (ALP1)

Target
ALP1
Molecular classification
Enzyme, Receptor, GPI-anchored protein, Hydrolase
01

Overview

GPI-anchored alkaline phosphatase (ALP), specifically the ALP1 isoform, is a membrane-bound enzyme predominantly expressed in the midgut epithelium of mosquito larvae, such as Aedes aegypti (Fernandez et al., 2006; Jimenez et al., 2012). It functions physiologically in the hydrolysis of phosphate esters and the transport of nutrients across the midgut membrane (Stalinski et al., 2016). In the field of vector control, this protein is highly significant as a primary functional receptor for the Cry toxins produced by Bacillus thuringiensis subsp. israelensis (Bti), including Cry11Aa and Cry4Ba (Likitvivatanavong et al., 2011). The interaction between these toxins and ALP is a critical step in the toxins' mechanism of action, where binding triggers toxin oligomerization and the formation of lethal pores in the larval midgut cells (Fernandez et al., 2006; Jimenez et al., 2012). This process leads to the destruction of the gut lining and the eventual death of the mosquito larvae (Lee et al., 2014). Due to its essential role in toxin-mediated mortality, ALP is a major focus for developing biopesticides and monitoring insecticide resistance in mosquito populations (Stalinski et al., 2016).

Other names
GPI-anchored alkaline phosphataseMembrane-bound alkaline phosphatasemALPAae-mALPAlkaline phosphatase
02

Mechanism of action

Binding of Cry toxins to the receptor facilitates toxin oligomerization, membrane insertion, and pore formation in midgut epithelial cells, leading to cell lysis and larval death.

03

Biological functions

Phosphate metabolismNutrient transportDigestionToxin receptor
04

Disease associations

InfectionDengueZika virus infectionYellow feverMalaria
05

Safety considerations

Insecticide resistanceNon-target insect toxicity
06

Interacting drugs

Cry11Aa toxin

3 more in the full profile.

07

Biomarkers

ALP1 expression levelAlkaline phosphatase activity

Beyond the preview

Go deeper on Alkaline phosphatase 1 (ALP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alkaline phosphatase 1 (ALP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call